Drug Database
Back to search

Poland· PL-100391865

Elmiron

A pentosan polysulfate sodium product containing natrii pentosani polysulfas, registered in Poland by bene Arzneimittel GmbH. The same ATC class is registered in 10 of our 19 countries.

ATC G04BX15

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedElmironATCG04BX15REGISTER NO.PL-100391865PACKS LISTED1CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about natrii pentosani polysulfasAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Pentosan polysulfate sodium is registered in 10 of 19 countries.

Countries holding a registration under ATC G04BX15 (pentosan polysulfate sodium), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 7 of them publish a price we can compare per daily dose
Search pentosan polysulfate sodium products by name

Pentosan polysulfate sodium · ATC G04BX15

10 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of pentosan polysulfate sodium costs, country by country.

Normalised to the WHO defined daily dose (0.3 g), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Pentosan polysulfate sodium · price per daily dose (0.3 g)

USD · FX 28 Sept 2026

  • CH Switzerland$19.03
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

URPL (Poland)
Active substance
Natrii pentosani polysulfas
Manufacturer
bene Arzneimittel GmbH
Country
Poland (PL)
ATC code
G04BX15
ATC class
Pentosan polysulfate sodium
Defined daily dose
0.3 g, O
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 1

  • gtin
    04260078520176

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

74 interactions on record for pentosan polysulfate sodium.

Graded by severity as the source publishes them — 74 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check pentosan polysulfate sodium against other medicinesHow interaction checks work

Pentosan polysulfate sodium · interactions on record

74 records

  • 74 moderate

Most severe, free to view

  • DicoumarolB01AA01moderate
  • WarfarinB01AA03moderate
  • HeparinB01AB01moderate
  • Antithrombin IIIB01AB02moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Pentosan polysulfate sodium in 12 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All pentosan polysulfate sodium products

Authorised across Europe · EMA

The same active substance is authorised in 9 EEA countries. Names it is sold under:

  • Czechia · Thrombocid
  • Germany · Thrombocid
  • Spain · Thrombocid, Thrombocid Forte
  • Hungary · Dimovena, Sp 54
  • Iceland · Elmiron
  • Italy · Fibrase
  • Liechtenstein · Elmiron
  • Norway · Elmiron
  • Portugal · Comfora, Thrombocid

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/837f6ec0-4402-4b6d-ad42-270e790b6cb2
GET /v1/drugs/837f6ec0-4402-4b6d-ad42-270e790b6cb2?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Kapsułki twarde",
  "source": "urpl",
  "strength": "100 mg",
  "packaging": "04260078520176 ¦ Rp ¦ EU/1/17/1189/001 ¦ 123760\n1 butelka 90 kaps.\nRp ¦ EU/1/17/1189/002 ¦ 126159\n90 kaps. w blistrze\nRp ¦ EU/1/17/1189/003 ¦ 131582\n300 kaps.",
  "substance": "Natrii pentosani polysulfas 100 mg",
  "common_name": "Natrii pentosani polysulfas",
  "pl_product_id": "100391865",
  "pozwolenie_nr": null,
  "auth_procedure": "CEN",
  "authorisation_validity": null
}
API referenceMCP serverPlans

See everything about pentosan polysulfate sodium.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console